英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

theobald    音标拼音: [θ'iəbəld]
n. 男子名

男子名


请选择你想看的字典辞典：
单词字典翻译
Theobald查看　Theobald　在百度字典中的解释百度英翻中〔查看〕
Theobald查看　Theobald　在Google字典中的解释Google英翻中〔查看〕
Theobald查看　Theobald　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Orange Book Data File Download Instructions
    Orange Book Data File Download Instructions A step-by-step guide to download the latest Orange Book monthly data to Microsoft Excel on Microsoft Windows*
  • Wegovy (semaglutide)
    You also must ensure that any changes to your approved NDA that require the submission of a request to remove patent information from the Orange Book are submitted to FDA at the time of approval of the supplement pursuant to 21 CFR 314 53(d)(2)(ii)(B) and 314 53(f)(2)(iv) 2 We update guidances periodically
  • Velphoro (sucroferric oxyhydroxide) chewable tablets
    Pursuant to 21 CFR 314 53(d)(2) and 314 70(f), certain changes to an approved NDA submitted in a supplement require you to submit patent information for listing in the Orange Book upon approval of the supplement
  • CENTER FOR DRUG EVALUATION AND RESEARCH
    Pursuant to 21 CFR 314 53(d)(2) and 314 70(f), certain changes to an approved NDA submitted in a supplement require you to submit patent information for listing in the Orange Book upon approval of the supplement
  • Draft Guidance on Isoniazid - Food and Drug Administration
    Isoniazid tablet is a DESI1 effective drug for which there are no known or suspected bioequivalence problems, and as such is rated “AA” in the FDA CDER’s Approved Drug Products with Therapeutic Equivalence Evaluations (“Orange Book”)
  • Approval Letter_215256Orig1s024ltr
    Pursuant to 21 CFR 314 53(d)(2) and 314 70(f), certain changes to an approved NDA submitted in a supplement require you to submit patent information for listing in the Orange Book upon approval of the supplement
  • Imbruvica (ibrutinib) capsules
    Pursuant to 21 CFR 314 53(d)(2) and 314 70(f), certain changes to an approved NDA submitted in a supplement require you to submit patent information for listing in the Orange Book upon approval of the supplement
  • Ibrance (palbociclib) capsules
    Pursuant to 21 CFR 314 53(d)(2) and 314 70(f), certain changes to an approved NDA submitted in a supplement require you to submit patent information for listing in the Orange Book upon approval of the supplement
  • Nexplanon - accessdata. fda. gov
    You also must ensure that any changes to your approved NDA that require the submission of a request to remove patent information from the Orange Book are submitted to FDA at the time of approval of the supplement pursuant to 21 CFR 314 53(d)(2)(ii)(B) and 314 53(f)(2)(iv)
  • Hydroxyzine Hydrochloride - Food and Drug Administration
    Hydroxyzine Hydrochloride Tablets are a DESI1 effective drug for which there are no known or suspected bioequivalence problems, and as such is rated “AA” in the FDA CDER’s Approved Drug Products with Therapeutic Equivalence Evaluations (“Orange Book”)





中文字典-英文字典  2005-2009